Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Yang, Tianxin  [Clear All Filters]
2015
Wang Y-Y, Yang Y-X, Zhao R, Pan S-T, Zhe H, He Z-X, Duan W, Zhang X, Yang T, Qiu J-X, et al. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. Drug Des Devel Ther. 2015;9:993-1026.
Zhou Z-W, Li X-X, He Z-X, Pan S-T, Yang Y, Zhang X, Chow K, Yang T, Qiu J-X, Zhou Q, et al. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. Drug Des Devel Ther. 2015;9:1511-1554.
Li J-P, Yang Y-X, Liu Q-L, Pan S-T, He Z-X, Zhang X, Yang T, Chen X-W, Wang D, Qiu J-X, et al. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Drug Des Devel Ther. 2015;9:1627-1652.
Li J-P, Yang Y-X, Liu Q-L, Zhou Z-W, Pan S-T, He Z-X, Zhang X, Yang T, Pan S-Y, Duan W, et al. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells. Drug Des Devel Ther. 2015;9:1027-62.
Pan S-T, Qin Y, Zhou Z-W, He Z-X, Zhang X, Yang T, Yang Y-X, Wang D, Qiu J-X, Zhou S-F. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Drug Des Devel Ther. 2015;9:1601-1626.
Pan S-T, Zhou Z-W, He Z-X, Zhang X, Yang T, Yang Y-X, Wang D, Qiu J-X, Zhou S-F. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach. Drug Des Devel Ther. 2015;9:937-68.
Chen X-W, He Z-X, Zhou Z-W, Yang T, Zhang X, Yang Y-X, Duan W, Zhou S-F. An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus. Clin Exp Pharmacol Physiol. 2015.